PPI PHARMACEUTICALS, LLC
Biotech · Private
Abbapolin small molecules that bind PLK1 polo-box domain and induce proteasome-mediated protein degradation for cancer therapy
- Grants
- $846K
- 3 awards
- Sector median: 1
- Raised
- —
- No Form D on record
- Contracts
- —
- No federal contracts on record
- Patents
- —
- No published records under this name
- Sector median: 2
Capital Timeline
Federal ↑Equity ↓201620182020202220242026
| Date | Event | Source | Amount |
|---|---|---|---|
| Federal grant· 1 of 2 same day | Department of Health and Human Services · Phase I · Polo-box PLK1 Inhibitors Target Tumors Resistant to ATP Competitive Compounds | $224,933 | |
| Federal grant· 2 of 2 same day | Department of Health and Human Services · Phase I · Polo box PLK Inhibitors Target Tumors Resistant to ATP Competitive Compounds | $224,933 | |
| Federal grant | Department of Health and Human Services · Phase I · Investigating Abbapolin PLK1 Polo Box Domain inhibitors as potential therapeutics for colorectal cancers | $395,724 |
Federal grant · SBIR/STTR
Peer position
| # | Company | Contracts | Disclosed equity |
|---|---|---|---|
| 2848 | DIGITAL NANOGENETICS, LLC | — | — |
| 2849 | RETINAL SOLUTIONS LLC | — | — |
| 2850 | Stipple Bio | — | $87M |
| 2851 | PPI PHARMACEUTICALS, LLC | — | — |
| 2852 | YOLO IMMUNE INC | — | — |
| 2853 | EMPHYMAB BIOTECH, LLC | — | — |
| 2854 | KSQ Therapeutics | — | $81M |
Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.